Michael Rowe

Two Labs, founded in 2003 and headquartered in Columbus, Ohio, is a leading pharmaceutical services company that partners with pharma and biotech companies across the globe. We know that no two paths to launch are alike, so we deliver customized integrated commercial solutions that guide our clients’ new product launches from clinical to commercial, as well as provide strategies for continued market viability for drugs already on the market. Our expertise and insights from more than 290+ launches have given us a proven track record of success across all major therapeutic areas with unmatched client satisfaction. In 2018, we embarked on a journey of unprecedented growth by acquiring Pennside Partners Ltd. and MKO Global Partners, and CEEK Enterprises in early 2020 before being acquired by London-based Envision Pharma Group later in 2020. In 2021, Two Labs then acquired Riparian, a consulting and SaaS company. As part of the global Envision Pharma Group family, we are proud to be backed by their best-in-class technology and artificial intelligence solutions, medical strategy, medical communications, publication planning & delivery, and patient engagement services, as well as offer access to their proprietary services through Okra.ai, 90TEN, and Riparian.